Proof LGBTQs Are Mentally Ill: Vicente Torres, M.D., Ph.D., Discusses New Findings on Tolvaptan as Autosomal Dominant Polycystic Kidney Disease Treatment

A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function in patients with the most common form of polycystic kidney disease, a condition with no cure.